{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:23:05Z","timestamp":1769696585484,"version":"3.49.0"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To reduce the risk of HIV transmission through transfusion, gay, bisexual and other men who have sex with men (gbMSM) are deferred from donating blood in many countries for varying lengths of time after having sex with another man. In 2021, screening algorithms to identify high\u2010risk sexual behaviours using gender\u2010neutral criteria (i.e., without any question on MSM or time deferral for MSM) were implemented in the United Kingdom based on recommendations in a report from the FAIR (For the Assessment of Individualised Risk) steering group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study examines the potential donation loss expected with these criteria if implemented in Canada.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Responses from blood donors regarding engagement in behaviours such as chemsex and anal sex with a new or multiple partners within 3\u2009months of donation were collected using an on\u2010site paper questionnaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Applying the FAIR criteria resulted in donation loss of 1.0% (95% CI: 0.8% \u2013 1.1%). Donation loss would be higher amongst younger donors aged 17\u201325 (2.0%, 95% CI: 1.6% \u2013 2.3%). Overall, 20% of donors reported feeling uncomfortable answering study questions but only 2.0% said it would stop them from donating.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Donation loss could be compensated by newly eligible gbMSM and with increased recruitment and encouraging donation from infrequent donors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tme.12888","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T10:21:14Z","timestamp":1655720474000},"page":"422-427","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Behaviour based screening questions and potential donation loss using the \u201cfor the assessment of individualised risk\u201d screening criteria: A Canadian perspective"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-9144","authenticated-orcid":false,"given":"Niamh","family":"Caffrey","sequence":"first","affiliation":[{"name":"Donation Policy &amp; Studies Canadian Blood Services  Ottawa Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Goldman","sequence":"additional","affiliation":[{"name":"Donation Policy &amp; Studies Canadian Blood Services  Ottawa Ontario Canada"},{"name":"Department of Pathology and Laboratory Medicine University of Ottawa  Ottawa Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Lewin","sequence":"additional","affiliation":[{"name":"Medical Affairs and innovation H\u00e9ma\u2010Qu\u00e9bec  Montreal Qu\u00e9bec Canada"},{"name":"Faculty of Medicine and Health Science Universit\u00e9 de Sherbrooke  Sherbrooke Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Osmond","sequence":"additional","affiliation":[{"name":"Donation Policy &amp; Studies Canadian Blood Services  Ottawa Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila F.","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Donation Policy &amp; Studies Canadian Blood Services  Ottawa Ontario Canada"},{"name":"School of Epidemiology and Public Health University of Ottawa  Ottawa Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"178","article-title":"Epidemiology of human immunodeficiency virus infection in blood donations in Europe and Italy","volume":"8","author":"Suligoi B","year":"2010","journal-title":"Blood Transfus"},{"key":"e_1_2_8_3_1","unstructured":"National AIDS Trust.HIV in the UK statistics. Accessed April 19 2022.https:\/\/www.nat.org.uk\/about-hiv\/hiv-statistics"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v47i01a11"},{"key":"e_1_2_8_5_1","unstructured":"SACTTI (Standing Advisory Committee on Transfusion Transmitted Infections).Joint United Kingdom (UK) blood transfusion and tissue transplantation services professional advisory committee. position statement: the estimated residual risk that a donation made in the infectious window period is not detected on testing: risks specific for HBV HCV and HIV in the UK; 2021. Accessed April 4 2022.https:\/\/www.transfusionguidelines.org\/document\u2010library\/horizon\u2010scanning\u2010management\u2010process\u2010description\u2010preparedness\u2010for\u2010emerging\u2010infectious\u2010agents\u2010january\u20102021"},{"key":"e_1_2_8_6_1","unstructured":"O'BrienSF.Surveillance report 2020. Accessed April 4 2022.https:\/\/professionaleducation.blood.ca\/en\/transfusion\/publications\/surveillance\u2010report"},{"key":"e_1_2_8_7_1","unstructured":"FAIR.Can donor selection policy move from a population\u2010based donor selection policy to one based on a more individualized risk assessment? Conclusions from the For the Assessment of Individualized Risk (FAIR) group; 2020. Accessed September 23 2022.https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco\u2010assets\u2010corp\/21001\/fair_sabto_20201211.pdf"},{"key":"e_1_2_8_8_1","unstructured":"Public Health Agency of Canada (PHAC). Estimates of HIV incidence Prevalence and Canada's Progress on Meeting the 90\u201090\u201090 HIV Targets; 2018. Accessed November 2021.https:\/\/www.canada.ca\/en\/public\u2010health\/services\/publications\/diseases\u2010conditions\/summary\u2010estimates\u2010hiv\u2010incidence\u2010prevalence\u2010canadas\u2010progress\u201090\u201090\u201090.html"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16165"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","unstructured":"PaquetteD DemersA Gale\u2010RoweM WongT.Brief\u2011Synopsis of the current evidence on the risk of HIV transmission. CCDR 39\u20101; November 2013. Accessed November 5 2021.10.14745\/ccdr.v39i01a02","DOI":"10.14745\/ccdr.v39i01a02"},{"key":"e_1_2_8_11_1","volume-title":"The Chemsex Study: Drug Use in Sexual Settings among Gay and Bisexual Men in Lambeth","author":"Bourne A","year":"2014"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-1127-6"},{"key":"e_1_2_8_13_1","unstructured":"Statistics Canada.Population estimates on July 1st by age and sex. Table 17\u201010\u20100005\u201001; 2021. Accessed December 9 2021.https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/cv.action?pid=1710000501"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732320952314"},{"key":"e_1_2_8_15_1","unstructured":"BBC News.The gay men who can donate blood in the UK for the first time. Produced by Rob Brown. Accessed November 8 2021.https:\/\/www.bbc.com\/news\/av\/uk-57469036."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00744.x"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12888","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tme.12888","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T16:13:51Z","timestamp":1692634431000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tme.12888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1111\/tme.12888"],"URL":"https:\/\/doi.org\/10.1111\/tme.12888","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"2021-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}